subject area of

• A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer  Academic Article
• A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma  Academic Article
• A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant‐eligible patients with previously untreated mantle cell lymphoma  Academic Article
• A multicenter, randomized trial of a nurse-led, home-based intervention for optimal secondary cardiac prevention suggests some benefits for men but not for women  Academic Article
• A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors  Academic Article
• A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors  Academic Article
• A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma  Conference Paper
• A phase Ib dose-escalation and expansion study of the BCL2 inhibitor nenetoclax combined with tamoxifen in ER and BCL2–positive metastatic breast cancer  Academic Article
• A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide  Academic Article
• A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme  Academic Article
• Activation of canonical BMP4-SMAD7 signaling suppresses breast cancer metastasis  Academic Article
• BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian ovarian cancer study group  Academic Article
• Biomarker Glycoprotein Acetyls is Associated with the Risk of a Wide Spectrum of Incident Diseases and Stratifies Mortality Risk in Angiography Patients  Academic Article
• Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate  Academic Article
• Combined BRAF (dabrafenib) and MEK inhibition (trametinib) in patients with BRAF V600 -mutant melanoma experiencing progression with single-agent BRAF inhibitor  Academic Article
• Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations  Academic Article
• Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma  Academic Article
• Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial  Academic Article
• Decision analysis of tamoxifen for the prevention of invasive breast cancer  Academic Article
• Detection of Circulating Tumor Cells in Colorectal Cancer by Immunobead-PCR Is a Sensitive Prognostic Marker for Relapse of Disease  Academic Article
• Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer  Academic Article
• Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program  Academic Article
• Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma.  Academic Article
• Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases  Academic Article
• Fc-gamma Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer  Academic Article
• Hepatocellular carcinoma and chemoembolization  Academic Article
• Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era  Academic Article
• Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™  Academic Article
• Impact of Nurse-Led, Multidisciplinary Home-Based Intervention on Event-Free Survival Across the Spectrum of Chronic Heart Disease  Academic Article
• Impact of a nurse-led home and clinic-based secondary prevention programme to prevent progressive cardiac dysfunction in high-risk individuals: the Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) randomized controlled study  Academic Article
• Ixazomib for relapsed or refractory multiple myeloma: review from an evidence review group on a NICE single technology appraisal  Academic Article
• Metabolic response evaluation for colorectal liver metastases and correlation to pathologic response and tumour markers.  Academic Article
• Myelodysplastic syndrome incidence, transfusion dependence, health care use, and complications: an Australian population-based study 1998 to 2008  Academic Article
• Na+/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: Molecular characterization of SMCT  Academic Article
• Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma  Academic Article
• Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial  Academic Article
• Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer  Academic Article
• Oral versus intravenous fluoropyrimidines for colorectal cancer  Academic Article
• Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance  Academic Article
• Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma  Academic Article
• PET Changes Management and Improves Prognostic Stratification in Patients with Head and Neck Cancer: Results of a Multicenter Prospective Study  Academic Article
• PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer  Academic Article
• Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia  Academic Article
• Patterns of care for metastatic renal cell carcinoma in Australia  Academic Article
• Phase II study of first‐line trebananib plus sorafenib in patients with advanced hepatocellular carcinoma  Academic Article
• Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma  Academic Article
• Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression  Academic Article
• Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: results of a multicentre prospective study  Academic Article
• Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study  Academic Article
• Predicting Clinical Outcome through Molecular Profiling in Stage III Melanoma  Academic Article
• Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer  Academic Article
• Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma  Academic Article
• Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab*  Academic Article
• Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma  Academic Article
• Rechallenge with Platinum plus Fluoropyrimidine +/– Epirubicin in Patients with Oesophagogastric Cancer  Academic Article
• Reply to M. Mohiuddin et al  Academic Article
• Reporting of Time-to-Event End Points and Tracking of Failures in Randomized Trials of Radiotherapy With or Without Any Concomitant Anticancer Agent for Locally Advanced Head and Neck Cancer  Academic Article
• Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles  Academic Article
• Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin's lymphoma.  Academic Article
• Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis  Academic Article
• Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029) : an open-label, phase 1b trial  Academic Article
• Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients Receiving Crizotinib  Academic Article
• Survival outcomes in elderly men undergoing radical prostatectomy in Australia  Academic Article
• Survival outcomes in renal transplant recipients with renal cell carcinoma or transitional cell carcinoma from the ANZDATA database  Academic Article
• Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer  Academic Article
• The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer  Academic Article
• The role of BRAF mutations in primary melanoma growth rate and survival  Academic Article
• Treating childhood acute myeloid leukaemia with the AML-BFM-83 protocol: experience in a developing country  Academic Article
• Tumour but not stromal expression of β 3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer  Academic Article